Asthma: LABA + Steroids Not a Winning Combo for Blacks – MedPage Today


MedPage Today

Asthma: LABA + Steroids Not a Winning Combo for Blacks
MedPage Today
Asthma exacerbations were not reduced in black adults when a long acting beta-agonist (LABA) was added to treatment with inhaled corticosteroids (ICS), a randomized trial concluded. The mean number of exacerbations was 0.42 exacerbations per …
Study compares combination treatments for black adults with asthma The JAMA EurekAlert (press release)

all 4 news articles »

View full post on asthma – Google News

Health Watch: Promising ‘Combo Inhaler’ For Asthma Patients – CBS Local

Health Watch: Promising 'Combo Inhaler' For Asthma Patients
CBS Local
MINNEAPOLIS (WCCO) — Nine people die from asthma each day in the U.S. Now, a new study looks at patients who have trouble controlling their condition and suggests possibly changing the way doctors treat them. Currently, many asthma patients have
Study suggests new treatment methods for asthma sufferersWNCT
NZ tech leads in treatment of asthmaNew Zealand Herald
Studies support combined prevention and rescue asthma inhalerNursing Times

all 5 news articles »

View full post on asthma – Google News

Single combo inhaler beats standard rx in asthma – Medical Xpress


Telegraph.co.uk

Single combo inhaler beats standard rx in asthma
Medical Xpress
Maintenance and reliever therapy with a single inhaled corticosteroid plus a rapid-onset, long-acting, ?2 agonist (formoterol) seems beneficial for patients with asthma, according to two studies published in the March issue of The Lancet Respiratory
Single Combined Asthma Inhaler Better Than Recommended TreatmentMedical News Today
Asthma: Single-Inhaler Therapy May Trump Standard CareMedscape
Combo Inhaler May Be Better for Some With AsthmaWebMD
Telegraph.co.uk –OnMedica –WebMD.Boots.com
all 9 news articles »

View full post on asthma – Google News

Combo Inhaler May Be Better for Some With Asthma – WebMD


Telegraph.co.uk

Combo Inhaler May Be Better for Some With Asthma
WebMD
"The SMART regime was more effective as a treatment for asthma than the conventional treatment, where you just use a inhaler at a fixed maintenance dose and a short-acting inhaler for the relief of symptoms," said Dr. Richard Beasley, director of the
Single Combined Asthma Inhaler Better Than Recommended TreatmentMedical News Today
Asthma: Single-Inhaler Therapy May Trump Standard CareMedscape
Dual-purpose asthma inhalers more effectiveTelegraph.co.uk
WebMD.Boots.com –Exchange Morning Post (press release)
all 5 news articles »

View full post on asthma – Google News

Combo Inhaler May Give Better Relief for Some With Asthma – U.S. News & World Report

Combo Inhaler May Give Better Relief for Some With Asthma
U.S. News & World Report
"The SMART regime was more effective as a treatment for asthma than the conventional treatment, where you just use a inhaler at a fixed maintenance dose and a short-acting inhaler for the relief of symptoms," said Dr. Richard Beasley, director of the
Single inhaler asthma therapy better at preventing attacks than recommended Exchange Morning Post (press release)

all 2 news articles »

View full post on asthma – Google News

Ventura bags major US partner for COPD/asthma combo copy – Pharma Times

Ventura bags major US partner for COPD/asthma combo copy
Pharma Times
division of an undisclosed leading international pharmaceutical company" for VR315, a combination therapy for chronic obstructive pulmonary disease and asthma that is widely thought to be a generic version of GlaxoSmithKline's blockbuster Advair.
Vectura Signs Up US Partner For VR315 Lung DrugNASDAQ
Vectura signs US license agreement for VR315 productStock Market Wire
Vectura gets new US partner for copy of lung drugReuters
The Pharma Letter –Pharmaceutical Business Review
all 13 news articles »

View full post on asthma – Google News

AAAAI: Long-Acting Beta Agonist Combo Okay for Kids – MedPage Today


Internal Medicine News Digital Network

AAAAI: Long-Acting Beta Agonist Combo Okay for Kids
MedPage Today
Explain that a single-center retrospective study found no increase in pediatric intensive care unit admissions for asthma patients on the combination of long-acting beta agonists and inhaled corticosteroids. Note that the study compared outcomes for
No Benefit to Increased Inhaled Steroids in Asthma ExacerbationInternal Medicine News Digital Network

all 2 news articles »

View full post on asthma – Google News